Skip to results
Modify your search
NARROW
1-19 of 19
Authors: Heinz‐Josef Lenz
Sort by
Journal Article
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors
Dan Morgenstern-Kaplan and others
The Oncologist, Volume 29, Issue 11, November 2024, Pages e1480–e1491, https://doi.org/10.1093/oncolo/oyae168
Published: 10 July 2024
Journal Article
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial
Alexander Spira and others
The Oncologist, Volume 28, Issue 2, February 2023, Pages e124–e127, https://doi.org/10.1093/oncolo/oyac254
Published: 28 December 2022
Journal Article
Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates
Julia Stal and others
The Oncologist, Volume 27, Issue 7, July 2022, Pages 579–586, https://doi.org/10.1093/oncolo/oyac052
Published: 15 April 2022
Journal Article
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial
Aminah Jatoi and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 610–618, https://doi.org/10.1002/onco.13730
Published: 06 March 2021
Journal Article
Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer
Alberto Sobrero and others
The Oncologist, Volume 26, Issue 2, February 2021, Pages e261–e269, https://doi.org/10.1002/onco.13591
Published: 14 December 2020
Journal Article
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer
Afsaneh Barzi and others
The Oncologist, Volume 25, Issue 12, December 2020, Pages e1879–e1885, https://doi.org/10.1634/theoncologist.2020-0642
Published: 27 August 2020
Journal Article
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer
Mohamed E. Salem and others
The Oncologist, Volume 25, Issue 5, May 2020, Pages 404–413, https://doi.org/10.1634/theoncologist.2019-0552
Published: 17 December 2019
Journal Article
Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer
Michael A. Morse and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages 1453–1461, https://doi.org/10.1634/theoncologist.2019-0129
Published: 30 May 2019
Journal Article
A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient‐Centeredness, and Practice Context
Jon Tilburt and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages e1180–e1189, https://doi.org/10.1634/theoncologist.2019-0093
Published: 17 May 2019
Journal Article
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Herbert I. Hurwitz and others
The Oncologist, Volume 24, Issue 7, July 2019, Pages 921–932, https://doi.org/10.1634/theoncologist.2018-0344
Published: 14 December 2018
Journal Article
Impact of Patient Age on Molecular Alterations of Left‐Sided Colorectal Tumors
Alberto Puccini and others
The Oncologist, Volume 24, Issue 3, March 2019, Pages 319–326, https://doi.org/10.1634/theoncologist.2018-0117
Published: 17 July 2018
Journal Article
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma
Mohamed E. Salem and others
The Oncologist, Volume 23, Issue 11, November 2018, Pages 1319–1327, https://doi.org/10.1634/theoncologist.2018-0143
Published: 04 June 2018
Journal Article
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
Donna Niedzwiecki and others
The Oncologist, Volume 22, Issue 1, January 2017, Pages 107–114, https://doi.org/10.1634/theoncologist.2016-0215
Published: 17 January 2017
Journal Article
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer
Lawrence Leichman and others
The Oncologist, Volume 21, Issue 2, February 2016, Pages 172–177, https://doi.org/10.1634/theoncologist.2015-0319
Published: 19 January 2016
Journal Article
Mucinous Adenocarcinomas with Intra-Abdominal Dissemination: A Review of Current Therapy
Thomas Winder and Heinz-Josef Lenz
The Oncologist, Volume 15, Issue 8, August 2010, Pages 836–844, https://doi.org/10.1634/theoncologist.2010-0052
Published: 23 July 2010
Journal Article
Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer
Claus-Henning Köhne and Heinz-Josef Lenz
The Oncologist, Volume 14, Issue 5, May 2009, Pages 478–488, https://doi.org/10.1634/theoncologist.2008-0202
Published: 01 May 2009
Journal Article
Management and Preparedness for Infusion and Hypersensitivity Reactions
Heinz-Josef Lenz
The Oncologist, Volume 12, Issue 5, May 2007, Pages 601–609, https://doi.org/10.1634/theoncologist.12-5-601
Published: 01 May 2007
Journal Article
Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors
Dirk Strumberg and others
The Oncologist, Volume 12, Issue 4, April 2007, Pages 426–437, https://doi.org/10.1634/theoncologist.12-4-426
Published: 01 April 2007
Journal Article
The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer
Richard M. Goldberg and others
The Oncologist, Volume 12, Issue 1, January 2007, Pages 38–50, https://doi.org/10.1634/theoncologist.12-1-38
Published: 01 January 2007
Advertisement
Advertisement